Abstract

As the cure rate for adolescents with cancer has improved, the focus on future reproductive potential has increased. Despite a concerted effort to reduce the impact of cancer treatment on fertility through the alteration of therapy and the implementation of protective measures, many adolescent women with cancer remain at risk for impaired reproductive potential. Although the only standard-of-care approach to fertility preservation in this population remains embryo cryopreservation, there has been intense development of oocyte and ovarian cryopreservation as viable alternatives. This article focuses on the developing modalities of fertility preservation for adolescent women diagnosed with cancer.

Authors

Fish JD

Institution

Survivors Facing Forward Program, Hematology/Oncology and Stem Cell Transplantation, Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York 11040, USA. JFish1@NSHS.EDU

Source

Adolescent medicine: state of the art reviews 23:1 2012 Apr pg 111-22, xi

MeSH

Adolescent
Antineoplastic Agents
Cryopreservation
Female
Fertility Preservation
Humans
Infertility, Female
Neoplasms
Risk Factors

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

22764558